West Pharma Announces Fourth-Quarter and Full-Year 2019 Results


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ West Pharma Announces Fourth-Quarter and Full-Year 2019
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2019 and introduced full-year 2020 financial guidance.

Fourth-Quarter and Full-Year 2019 Summary (comparisons to prior-year period)

Fourth-quarter 2019 net sales of $470.6 million grew 11.4%; organic sales growth was 12.7%; sales from a recent acquisition contributed an additional 30 basis points of growth; currency translation reduced sales by 160 basis points.

Full-year 2019 net sales of $1.840 billion grew 7.1%; organic sales growth was 10.0%; sales from a recent acquisition contributed an additional 10 basis points of growth; currency translation reduced sales by 300 basis points.

Fourth-quarter 2019 reported-diluted EPS of $0.84 increased 22%. Full-year 2019 reported-diluted EPS of $3.21 increased 17%.

Fourth-quarter 2019 adjusted-diluted EPS of $0.82 increased 12%. Full-year 2019 adjusted-diluted EPS of $3.24 increased 15%.

Company is introducing full-year 2020 financial guidance of net sales in a range of $1.95 billion to $1.97 billion and reported-diluted EPS in a range of $3.45 to $3.55.

"Adjusted-diluted EPS" and "organic sales growth" are Non-U.S. GAAP measurements. See discussion under the heading "Non-U.S. GAAP Financial Measures" in this release.

"I am pleased to report strong fourth-quarter 2019 sales and EPS growth, which continues a trend seen throughout the year," said Eric M. Green, President and Chief Executive Officer. "We had double-digit organic sales growth in all three market units of our Proprietary Products segment. High-value products (HVPs) once again fueled sales growth and gross margin expansion, led by Daikyo® and Westar® components."

Mr. Green continued, "We are introducing full-year 2020 financial guidance that is in line with our long-term financial construct of organic sales growth and operating margin expansion. Our end markets are stable and growing, and we are off to a good start to 2020 with a strong book of committed orders for our high value products, such as NovaPure® and Envision® components, as well as Daikyo Crystal Zenith® containers and our portfolio of self-injection delivery platforms. Our teams across the globe have demonstrated their passion for customers throughout 2019, with new product and services offerings, and are poised to deliver another strong year of sales and profit growth for our business in 2020."

Tags : #Westpharma #Q4result #Financialguidancefor2020

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Immuneel Therapeutics and THSTI Announce Strategic Partnership to Advance CAR-T Cell Therapy and Lentiviral Vector Manufacturing July 28, 2026
Differential Diagnosis of Acute Abdomen: Differentiating Surgical Emergencies from Gastrointestinal MimicsJuly 28, 2026
Management of Rheumatic Heart Disease in Developing Nations: Secondary Prophylaxis and Valve InterventionsJuly 28, 2026
Hormonal Imbalance in Women: Understanding the Causes, Recognising the Symptoms, and Finding the Right TreatmentJuly 28, 2026
Why Regular Health Screening Matters: A Complete Guide for IndiansJuly 28, 2026
Galderma introduces Sculptra® in India, ushering in a new era of regenerative aestheticsJuly 27, 2026
Artificial Intelligence in Diagnostic Imaging: Enhancing Radiologist Precision and Reducing Human ErrorJuly 27, 2026
Transitioning from Acute Care to Urgent Care Centers: Optimizing Healthcare Facility InfrastructureJuly 27, 2026
Ahead of World Head & Neck Cancer Day, HNCII Launches “Delay is the Real Killer” Cancer Awareness CampaignJuly 25, 2026
Ahead of World Head & Neck Cancer Day, HNCII Launches “Delay is the Real Killer” Cancer Awareness CampaignJuly 25, 2026
Menopause Symptoms Explained: What Every Indian Woman Should KnowJuly 25, 2026
Sleep Deprivation and Its Hidden Impact on Your Health: What Every Indian Should KnowJuly 25, 2026
Air Pollution and Health Effects: What Every Indian Must KnowJuly 25, 2026
NABH Accreditation Explained: What It Means for Indian Hospitals and PatientsJuly 25, 2026
Hypertension in Young Indians: Causes and Early InterventionJuly 24, 2026
How Stress Damages Your Heart: The Mind-Body ConnectionJuly 24, 2026
Living with Arthritis in India: Pain Management and Lifestyle TipsJuly 23, 2026
Iron Deficiency vs B12 Deficiency: Spotting the Difference in IndiansJuly 23, 2026
The ePlane Company and Apollo Hospitals Join Forces to Bring India's Golden Hour Within ReachJuly 23, 2026
Importance of Women's Health Screening: A Comprehensive Guide to Preventive CareJuly 23, 2026